EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Account-Based Marketing (ABM) Drives Pharma Event Success and Lead Generation
For pharmaceutical companies conferences trade shows scientific congresses and industry networking events continue to be some of the most valuable channels for building relationships Yet many organizations still measure event success using outdated metrics such as booth visitors badge scans promotional giveaways or the total number of leads collected
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Antibiotic Resistance 101: What Everyone Needs to Know About Superbugs
Debi Jones
The two threats to global health are bacterial resistance because bacteria populations can modify themselves to become resistance to the essential medicines needed to manage infections. It defines the...
-
2
Unlocking the Power of Biomarkers: A Comprehensive Guide
Kate Williamson
Biomarkers, spanning genes, proteins, and imaging features, are pivotal in healthcare, offering insights into disease, personalized treatment, and drug development. Challenges include standardization...
-
3
RNA Revolution: Advancing Drug Discovery through Targeted Molecules
Kate Williamson
The RNA revolution in drug discovery has introduced targeted molecules like ASOs, siRNA, and RNA vaccines, offering precise gene modulation and therapeutic versatility across genetic disorders, neurod...
-
4
Understanding Over-the-Counter (OTC) Drugs: Trends and Opportunities in Pharma
Kate Williamson
This article explores the growing role of over-the-counter (OTC) drugs in global healthcare, highlighting current trends such as increased health awareness, technological advancements, and an aging po...
-
5
From Pipelines to Platforms: How AI Investments Are Transforming Biotech and Pharma’s Operating Model
Kishore Raju Vatsavai
Artificial intelligence (AI) is becoming a strategic priority across the pharmaceutical industry. Companies are investing heavily in AI to improve research productivity, accelerate drug discovery, and...
press releasesRead more...
FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing
FUJIFILM Biotechnologies Fujifilm a worldleading contract development and manufacturing organization CDMO for biologics vaccines and advanced therapies today announced that its commercialscale
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
Tarsus Pharmaceuticals Inc NASDAQ TARS today announced the acquisition of iRenix Medical Inc a privately held clinicalstage ophthalmic biopharmaceutical company and developer of IRX
Marcus Evans Announces the Value-Based Care Summit 2026 — An Invitation-Only Executive Forum Redefining the Future of Healthcare
Marcus Evans a global leader in premium business intelligence and executive events with over years of experience is proud to announce the ValueBased Care Summit an exclusive invitationonly gathering designed for senior executives at the forefront of transforming healthcare delivery and reimbursem...
Codis To Acquire Catalent's Nottingham, UK Facility to Create Europe's Leading End-to-End Spray Dry Capability
Codis a global contract development and manufacturing organization CDMO specializing in spray drying amorphous solid dispersions ASDs and advanced particle engineering solutions today announced an agreement with Catalent Pharma Solutions
Events Read more...
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
LATEST NEWSRead more...
Catalent and Nanoscope Therapeutics Expand Partnership for MCO-010 Development and Commercial Supply
Catalent and Nanoscope Therapeutics have expanded their partnership to support the latestage clinical development and future commercial supply of MCO Nanoscopes lead optogenetic gene therapy for retinal degenerative diseases
Certara Partners with NVIDIA to Advance AI-Driven Drug Discovery and Development
Certara has partnered with NVIDIA to enhance its open integrated artificial intelligence AI platform bringing together its scientific software regulatory expertise and proprietary datasets with AIfirst agentbased technologies to support drug discovery and development
Abbisko Therapeutics and AstraZeneca Partner to Advance NSCLC Combination Therapy Trial
Abbisko Therapeutics has entered into a strategic collaboration with AstraZeneca to jointly advance the clinical development of a combination therapy for nonsmall cell lung cancer NSCLC
Insilico Medicine and Takeda Collaborate to Advance AI-Driven Drug Discovery
Insilico Medicine has entered into a strategic collaboration with Takeda to use its proprietary PharmaAI platform to support the discovery and development of new drug candidates across Takedas therapeutic areas
Abbisko Therapeutics and AstraZeneca Partner on Clinical Trial for NSCLC Combination Therapy
Abbisko Therapeutics has entered into a strategic collaboration with AstraZeneca to jointly advance the clinical development of a new immunooncology and targeted therapy combination for the treatment of nonsmall cell lung cancer NSCLC
Monopar Therapeutics Receives US FDA Rare Pediatric Disease Designation for ALXN1840
Monopar Therapeutics has received Rare Pediatric Disease RPD designation from the US Food and Drug Administration FDA for ALXN tiomolibdate choline its latestage investigational treatment for Wilson disease
